Carmella Reveals Lynch Syndrome Diagnosis
The former WWE star disclosed the inherited cancer-risk condition on her podcast after a follow-up procedure following abnormal Pap smear results.
Updated on Nov. 4, 2026 in Cancer
Carmella, the former WWE wrestler whose real name is Leah Van Dale, revealed she was diagnosed with Lynch syndrome on her Hot Mom Sh*t podcast. She said abnormal Pap smear results led to a follow-up procedure, and the results of that procedure came back clear.
Why it matters
Lynch syndrome is an inherited condition that raises the risk of several cancers, and Carmella's mother had endometrial cancer. Her disclosure highlights how family history can prompt genetic testing and closer medical monitoring for people across the United States.
The disclosure is a first-person account rather than a clinical study, reporting that Carmella had known of her possible inherited risk for 12 or 13 years before testing. Medical details beyond the clear follow-up result, including the specific cells examined, were not provided.
The players
Carmella (Leah Van Dale)
A former WWE wrestler who has been open about her personal life and family health history on her podcast.
Corey Graves
A WWE commentator and former wrestler who is married to Carmella and is the father of their two children.
The details
Carmella said she thought about getting tested after she and Corey Graves welcomed two children. She has not wrestled since March 2023, and her WWE contract expired in February 2025.
Timeline
March 2023: Carmella last wrestled.
February 2025: Carmella's WWE contract expired.
A couple of weeks before the podcast episode: Abnormal Pap smear results returned.
Big Picture
Lynch syndrome is an inherited condition that elevates risk for several cancers, and public disclosures like Carmella's have increased awareness of hereditary cancer screening. Her account places the condition in the context of family history prompting testing rather than symptoms alone.
Anyone with a family history of endometrial, colorectal, or other cancers may consider discussing genetic testing with a doctor. Follow-up procedures after abnormal screening results are a common part of monitoring for hereditary risk.
The takeaway
Family history is a useful starting point for asking a doctor whether genetic testing for inherited cancer risk makes sense. Carmella's experience shows that follow-up testing after an abnormal result can bring reassurance as well as early answers.
Further reading
Explore more on Cancer and how inherited risks shape screening decisions.
